Cardioselective beta blockers is contraindicated in
**Cardioselective Beta Blockers and Contraindications**
**Core Concept**
Cardioselective beta blockers are a type of beta blocker that preferentially block beta-1 receptors in the heart, reducing heart rate and contractility with less effect on beta-2 receptors in the lungs and other smooth muscle. This property makes them a safer choice for patients with asthma or chronic obstructive pulmonary disease (COPD).
**Why the Correct Answer is Right**
Cardioselective beta blockers are contraindicated in patients with asthma or COPD because they can cause bronchoconstriction by blocking beta-2 receptors in the lungs. This can lead to worsening respiratory symptoms and even respiratory failure. The mechanism involves the blockade of beta-2 receptors, which normally cause bronchodilation. Without these receptors activated, the airways constrict, making breathing more difficult.
**Why Each Wrong Option is Incorrect**
**Option A:** Not applicable, as this is a contraindication specific to cardioselective beta blockers.
**Option B:** While beta blockers can affect glucose metabolism, they are not contraindicated in diabetes per se; however, caution is advised when initiating beta blockers in diabetic patients.
**Option C:** This option is incorrect as cardioselective beta blockers are safer in patients with heart failure, as they reduce the workload on the heart without causing unacceptable bronchoconstriction.
**Option D:** This option is incorrect as cardioselective beta blockers are not contraindicated in patients with hypertension; in fact, they are often used to manage hypertension.
**Clinical Pearl / High-Yield Fact**
When initiating beta blockers, especially cardioselective ones, it's essential to assess the patient's respiratory status and consider their asthma or COPD history to avoid potential bronchoconstriction.
**Correct Answer:** D. Hypertension